Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 1

Bevacizumab in the therapy for refractory metastatic colorectal cancer

Total article views   HTML views PDF downloads Totals
7,000 Dovepress* 7,000+ 1,957 8,957
Totals 7,000 1,957 8,957
*Since 7 March 2008
+Since July 2016

View citations on Google Scholar